Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRIME-LRT: PRomoting IMmunotherapy Efficacy With Low-Dose Liver RT

NCT07225036 is registered in ClinicalTrials.gov with Jordan Kharofa as lead sponsor.

NCT NCT07225036
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07225036 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRIME-LRT: PRomoting IMmunotherapy Efficacy With Low-Dose Liver RT
Lead sponsor
Jordan Kharofa
Phase
Not applicable
Overall status
Recruiting
Start date
December 15, 2025
Completion date
December 15, 2029
Enrollment
21 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver metastases, low-dose liver radiation (ld-lrt), melanoma, non small cell lung cancer